December 2nd 2021
press releases
For a copy of this Analyst report please contact your Jefferies advisor.
December 1st 2021
analyst reports
November 26th 2021
press releases
November 26th 2021
press releases
November 26th 2021
press releases
For a copy of this Analyst report please contact your Taylor Collison advisor.
November 23rd 2021
analyst reports
Upcoming Events
What's next.
January 5th 2022 - January 7th 2022
read more
January 10th 2022 - January 14th 2022
read more
passion.
It takes a great deal of passion to pursue the fight against cancer and autoimmune diseases. We put our heart and soul into winning it.
know-how.
Our goal is to gather the strongest forces, the brightest minds and the most dedicated employees.
research.
Accurate research and development is the strongest foundation for developing effective treatments.
What is LAG-3?
Lymphocyte-activation gene 3, or LAG-3 (LAG-3), is a gene that provides the genetic information to make a cell surface molecule with biologic effects on T cell function.
LAG-3 is being used for many immunotherapy treatments including Eftilagimod Alpha from Immutep.
